Skip to content
StockMarketAgent
Real Estate / REIT - SpecialtyUpdated 2026-05-10 22:07 UTC

BME/YPSN stock hub

BME/YPSN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BME/YPSNis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
31.3M
Madrid Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BME/YPSN
In the news

Latest news · BME/YPSN

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E33.6
P25 n/aP50 n/aP75 n/a
ROE4
P25 n/aP50 n/aP75 n/a
ROIC3.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BME/YPSN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
169
Groups with data
11
Currency
EUR
Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
Spain
Country code
ES
Enterprise value
EUR 39.8M
Exchange
Madrid Stock Exchange
Financial currency
EUR
First seen
2026-05-10
Industry
REIT - Specialty
Isin
ES0170756037
Last refreshed
2026-05-10
Market cap
EUR 31.3M
Price
EUR 16.1
Price currency
EUR
Sector
Real Estate
Sic
6311
Symbol
bme/YPSN
Website
https://www.psnsocimi.es

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
2.97%
EV Earnings
42.73x
EV/EBIT
32.18x
EV/EBITDA
25.05x
EV/Sales
16.76x
P/B ratio
1.35x
P/E ratio
33.62x
P/S ratio
13.19x
PE Ratio10 Y
58.27x
PE Ratio3 Y
49.28x
PE Ratio5 Y
58.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
52.09%
EBITDA Margin
66.89%
Gross margin
75.76%
Gross Profit
EUR 1.8M
Net Income
EUR 932,533
Net Income Growth
71.75%
Net Income Growth Q
46.35%
Net Income Growth3 Y
32.33%
Net Income Growth5 Y
12.71%
Pretax Margin
40.39%
Profit Margin
39.22%
ROA
2.36
Roa5y
1.78
ROCE
3.89
ROE
4.04
Roe5y
2.93
ROIC
3.73
Roic5y
2.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

18
MetricValue
Cagr1y
2%
Cagr3y
1.77%
Cagr5y
1.48%
Div CAGR3
21.02%
Div CAGR5
10.1%
EPS Growth
71.94
EPS Growth Q
46.42
EPS Growth3 Y
32.39
EPS Growth5 Y
12.73
OCF Growth
14.16%
OCF Growth Q
3.1%
OCF Growth10 Y
13.64%
OCF Growth3 Y
12.97%
OCF Growth5 Y
23.38%
Revenue Growth
25.28x
Revenue Growth Q
19.11x
Revenue Growth3 Y
10.28x
Revenue Growth5 Y
3.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Asset Turnover
EUR 0.07
Assets
EUR 32.5M
Cash
EUR 310,836
Debt
EUR 8.8M
Debt EBITDA
EUR 5.54
Debt Equity
EUR 0.38
Equity
EUR 23.2M
Interest Coverage
4.01
Liabilities
EUR 9.3M
Net Cash
EUR -8.5M
Net Cash By Market Cap
EUR -27.11
Net Debt EBITDA
EUR 5.34
Net Debt Equity
EUR 0.37
Tangible Book Value
EUR 23.2M
Tangible Book Value Per Share
EUR 11.92
WACC
4.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
0.68
Net Working Capital
EUR 52,938
Quick ratio
0.68
Working Capital
EUR -229,316

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
0.11%
Dividend Growth
11.39%
Dividend Growth Years
4%
Dividend per share
EUR 0.39
Dividend Years
8
Dividend Yield
2.42%
Ex Div Date
2025-11-12
Last Dividend
EUR 0.11
Payout Frequency
Semi-Annual
Payout Ratio
73.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

31
MetricValue
1Y total return
2%
200-day SMA
16.02
3Y total return
5.42%
50-day SMA
16.1
50-day SMA vs 200-day SMA
50over200
5Y total return
7.62%
All Time High
17
All Time High Change
-5.29%
All Time High Date
2021-12-27
All Time Low
11.3
All Time Low Change
42.44%
All Time Low Date
2019-06-03
ATR
0
Beta
0.04
Beta1y
-0.04
Beta2y
-0.02
High
16.1
High52
16.2
High52 Date
2026-03-23
High52ch
-0.62%
Low
16.1
Low52
15.78
Low52 Date
2025-07-07
Low52ch
2%
Ma50ch
0%
Price vs 200-day SMA
0.51%
RSI
78.9
RSI Monthly
56.32
RSI Weekly
67.78
Sharpe ratio
-1.05x
Total Return
2.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR 1.2M
Operating margin
52.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

3
MetricValue
Float
120,343%
Shares Out
1,947,133
Shares Qo Q
0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

40
MetricValue
Average Volume
0x
Bv Per Share
11.92
Ch6m
1.26
Change
0%
Change From Open
0
Close
16.1
Days Gap
0
Depreciation Amortization
351,965
EBIT
EUR 1.2M
EBITDA
EUR 1.6M
EPS
EUR 0.48
F Score
5
Financing CF
-1,424,035
Fiscal Year End
December
Graham Number
11.332
Graham Upside
-29.61
Income Tax
EUR 27,689
Investing CF
-262,061
Is Primary Listing
1
Last Report Date
2022-12-31
Lynch Fair Value
EUR 6.09
Lynch Upside
-62.2
Ma150
16.06
Ma150ch
0.27%
Ma20
16.1
Ma20ch
0%
Net CF
-132,141
Open
16.1
P OCF Ratio
20.17
Payment Date
2025-11-14
Ppne
32,036,584
Price Date
2026-05-06
Price EBITDA
EUR 19.71
Ptbv Ratio
1.35
Relative Volume
19.61x
Revenue
2,377,519x
Tax By Revenue
1.16x
Tax Rate
2.88%
Tr6m
1.99%
Volume
0
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

BME/YPSN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.4%
$0.39 annual per share
Payout ratio
+73.1%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+10.1%
4 consecutive years of growth
Total shareholder yield
+2.5%
Next ex-dividend date: 2025-11-12
Performance

BME/YPSN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+2.0%
S&P 500 1Y: n/a
3Y total return
+5.4%
S&P 500 3Y: n/a
5Y total return
+7.6%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Technical

BME/YPSN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
78.9
Above 70: short-term overbought
Price vs 200-day MA
+0.5%
50/200-day relationship not available
Beta (5Y)
0.04
Less volatile than the market
Sharpe ratio
-1.05
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BME/YPSN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bme/YPSN stock rating?

bme/YPSN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bme/YPSN analysis?

The full report lives at /stocks/bme/YPSN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bme/YPSN?

The latest report frames bme/YPSN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bme/YPSN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bme/YPSN stock profile: metrics, valuation and analysis | AI-Agent voor de Aandelenmarkt